Grafa News and Videos — Page 386

Allergan Aesthetics, an AbbVie company (NYSE:ABBV), received European approval for Boey across 30 countries, with effects observed from eight hours.

Kimbell Royalty Partners (NYSE:KRP) agreed to acquire multi-basin royalty interests for $215.4 million, adding expected Q3 production of 2,347 boe/d.

Intuitive Surgical (NASDAQ:ISRG) shares fell more than 12% after the company maintained 13.5%–15.5% procedure-growth guidance and flagged insurance pressure.

SpaceX (NASDAQ:SPCX) shares fell 3.5% to $126.58 premarket after an engine failure aborted Starship’s 13th test before liftoff.

Veradermics (NYSE:MANE) presented age-based VDPHL01 data from Study ‘302,’ a 519-patient trial in males with mild-to-moderate pattern hair loss.

Solstice Advanced Materials (NASDAQ:SOLS) declared a regular quarterly dividend of $0.075 per common share, payable on September 10, 2026.

Kalaris Therapeutics (NASDAQ:KLRS) reported expanded Phase 1a TH103 data from 20 patients, with plasma exposure up to 53-fold below leading anti-VEGF agents.

ConocoPhillips (NYSE:COP) agreed to acquire a 42% interest in BP’s (NYSE:BP) Kirkuk venture, covering four producing fields and more than 3 billion barrels of oil equivalent.

GSK (NYSE:GSK) ended camlipixant development for chronic cough after CALM-2 missed its primary endpoint at 50mg.

Truist Financial (NYSE:TFC) reported Q2 2026 revenue of $5.23 billion and EPS of $1.08, matching profit expectations but narrowly missing revenue forecasts.